Shimadzu

Global Radiography Systems Market Analysis Report 2022: A $40 Billion Industry by 2028 - Size, Segments, Outlook, and Revenue Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 17, 2023
Health, Medical Devices, Technology, Health Technology, Other Technology, Other Health, Hardware, Product type, Joint, Cardiovascular disease, Swelling, Hospital, HRCT, Infection, Hospital Insurance and Diagnostic Services Act, COVID-19, Shimadzu, GE Healthcare, Agfa-Gevaert, Conditional sentence, Pregnancy, CT, Esaote, Osteoarthritis, Diagnosis, Patient, Prevalence, Diabetes, CT scan, Cancer, Canon Medical Systems Corporation, MRI, Spinal cord injury, Mammography, Carestream Health, General Electric Company, Network tomography, Pharmaceutical industry, Medical imaging, Unilab, Fujifilm

The "Global Radiography Systems Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, Application, End User and Regions" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiography Systems Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, Application, End User and Regions" report has been added to ResearchAndMarkets.com's offering.
  • According to this analysis, the Global Radiography Systems Market was valued at ~US$ 25 billion in 2017, it is estimated to be ~US$ 30 billion in 2022 and is expected to grow at a ~5% CAGR during 2022 to 2028, with market size of ~US$ 40 billion in 2028.
  • Increasing use of AI-enabled diagnostic equipment for rapid diagnosis and predictive analysis, notably in developed countries is one of the major contributing factors to the rising demand for radiography systems.
  • The ongoing COVID-19 pandemic has adversely affected the global radiography systems market in 2020, primarily due to a decline in patient visits to hospitals and clinics.

Life Science Tools Market Report 2022: Featuring Agilent Technologies, F. Hoffmann-La Roche, Merck, Hitachi & More - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 29, 2022
Health, Biotechnology, Thermo Fisher Scientific, QIAGEN, US, Hitachi, BD, Shimadzu, Merck Group, Marketing, Agilent Technologies, Fine chemical

This report provides an in-depth analysis of the global life science tools market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year.

Key Points: 
  • This report provides an in-depth analysis of the global life science tools market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year.
  • Adoption of organic strategies such as technological infrastructure by key market players is expected to drive the global life science tools market over the forecast period.
  • For instance, in April 2021, Genome Medical, Inc., a genomic technology company, announced the expansion of its technology infrastructure to accelerate delivery of virtual genomic medicine.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
    The global life science tools market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
    Global Life Science Tools Market, By Technology:

Shimadzu Medical Systems USA receives an IMV ServiceTrak Award in the R/F Systems category

Retrieved on: 
Monday, November 28, 2022
SMS, IMV, Hospital, Direct operations, Kenmore, Intervention, Marketing, Google Images, Business, Mobile phone, Medical imaging, Shimadzu

TORRANCE, Calif., Nov. 28, 2022 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, receives an IMV ServiceTrak Award in the R/F Systems category

Key Points: 
  • TORRANCE, Calif., Nov. 28, 2022 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, receives an IMV ServiceTrak Award in the R/F Systems category
    IMV produces a series of proprietary ServiceTrak reports derived from extensive online surveys or phone interviews with radiology professionals in U.S. hospitals and non-hospital locations from IMV's master database of Radiographic Fluoroscopy X-ray system locations.
  • This 2022 ServiceTrak survey results from interviews with 412 diagnostic imaging sites that have 497 unique systems.
  • Visit IMV at: www.imvinfo.com
    Shimadzu Medical Systems USA, a division of Shimadzu Precision Instruments, Inc., a wholly owned subsidiary of Shimadzu Corporation, is its medical business subsidiary in USA.
  • For further information about Shimadzu Medical Systems USA or other activities of Shimadzu in North America, please contact us at [email protected] .

To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research

Retrieved on: 
Tuesday, November 22, 2022
Cosmos, Amyloid, Self-assessment, Dementia, Diagnosis, PET, Oita University, Attention, MCI, Blood, Ministry, Brain, Physician, AD, Patient, Scientific method, Faculty, Medical school, Cerebrospinal fluid, Department of Neurology, Xuanwu hospital, Shimadzu, Research, Ecosystem, Memory, Amyloid beta, Ministry of Health, Labour and Welfare, CSF, Medical imaging, Health, Eisai, Alzheimer's disease, Neurology, Medicine

This joint study will attempt to develop Japan's first diagnostic workflow for mild cognitive impairment (MCI) and Alzheimer's disease (AD) that uses blood biomarkers.

Key Points: 
  • This joint study will attempt to develop Japan's first diagnostic workflow for mild cognitive impairment (MCI) and Alzheimer's disease (AD) that uses blood biomarkers.
  • Usuki City Medical Association will recruit applicants (50 years and older) who wish to participate in the study.
  • Primary care physicians affiliated with Usuki City Medical Association will perform simple cognitive function tests on applicants and select around 200 people with suspected MCI or mild dementia.
  • With this joint research, the four parties aim to establish a new diagnostic workflow for Alzheimer's disease that is based on blood biomarkers and includes primary care physicians.

Global Laboratory Balances and Scales Market Report to 2029 - Featuring A&D Company, Metler Toleda International, Sartorius and Adam Equipment Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, November 21, 2022
Biotechnology, Chemicals, Plastics, Health, Manufacturing, Shimadzu, Sartorius AG, Region, USD, Food safety, Avery Weigh-Tronix, Danaher Corporation, Research report, Fine chemical

The "Laboratory Balances and Scales Market Analysis by Product, by End user, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Laboratory Balances and Scales Market Analysis by Product, by End user, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The laboratory balances and scales market size is estimated to be USD 1.5 billion in 2021 and is expected to witness a CAGR of 5.73% during the forecast period 2022-2029.
  • The technological improvements in laboratory & balances & scales, rising public awareness of the need for strict food safety regulations, and development of pharma-biotech companies' research pipelines are projected to drive the market growth in near future.
  • This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and end user from 2021 to 2029.

The Global Neurological Biomarkers Market size is expected to reach $12.9 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period

Retrieved on: 
Thursday, November 24, 2022
Prevalence, AD, Metabolomics, Multiple sclerosis, EGFR, Type, Alzheimer's disease, World Health Organization, Parkinson's disease, Dementia, WHO, Prognosis, Health status of Asian Americans, KRAS, Drug development, Chemical safety, Literature, BRAF, Precision medicine, Medicine, Cancer, Biomarker, Research, International Labour Organization, Merck Group, Shimadzu, Disease, Myriad Genetics, Public health, LTD, COVID-19, Stroke, United States International Programming to Ukraine and Neighboring Regions, Nutrient, United Nations, Diagnosis, Health, First Nations in Ontario, Patient, Incidence, Medical imaging, Pharmaceutical industry, Application, Genomics

View original content:https://www.prnewswire.com/news-releases/the-global-neurological-biomark...

Key Points: 
  • NEW YORK, Nov. 24, 2022 /PRNewswire/ -- The Global Neurological Biomarkers Market size is expected to reach $12.9 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period.
  • Based on the Type, the Neurological Biomarkers Market is segmented into Genomic, Proteomic, Metabolomic, and Others.
  • On the basis of Application, the Neurological Biomarkers Market is divided into Parkinsons Disease, Alzheimers Disease, and Multiple Sclerosis.
  • The North America segment garnered the highest revenue share in the neurological biomarkers market in 2021.

CRAG and IRTA Expand Their International Partnership With Front Range Biosciences to Address the Growing Threat of Hop Latent Viroid Disease in Cannabis

Retrieved on: 
Thursday, November 10, 2022
GLOBE, Center of excellence, Seed, Molecular biology, Food, Center, Ministry, Autonomous university, Partnership, Research, UAB, Spanish National Research Council, Adoption, Organization, Environment, Plant, Population, CERCA, CSIC, Innovation, AEMPS, Efficiency, Genetics, Institute, MAS, UB, Government, University of Barcelona, FRB, Spanish Agency of Medicines and Medical Devices, Shimadzu, Breeding, Union, President of the Government of Catalonia, Autonomous University of Barcelona, IRTA, Medical device, DACC, Cannabis, University, Agriculture, Animal, CEO, Industry, Chemistry, Aquaculture, Drug, Science, Technology, Medicine, Health

These techniques add to the suite of already existing licensed technologies, including phytochemical quantification and molecular marker analysis, for commercial use to the CRAG and IRTA.

Key Points: 
  • These techniques add to the suite of already existing licensed technologies, including phytochemical quantification and molecular marker analysis, for commercial use to the CRAG and IRTA.
  • "CRAG is a world-class research center, and we are pleased to extend our partnership with them by introducing technologies and services that will transform cannabis markets across Europe," says Chris Driessen, CEO of FRB.
  • Spain was one of the first European countries to decriminalize the personal use and cultivation of cannabis for self-consumption.
  • Since 2016, CRAG is recognized as a "Severo Ochoa Centre of Excellence" by the Spanish Ministry of Science and Innovation.

Process Analytical Technology Market worth $6.1 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, October 21, 2022
Adoption, Critical process parameters, PAT, Product-service system, Growth, ABB, CAGR, Drug development, Research, Waters Corporation, PerkinElmer, Shimadzu, Danaher Corporation, Technology, CPP, Mass spectrometry, Carl Zeiss AG, Agilent Technologies, Safety, Bruker, Chromatography, Biophysics, USD, Biochemistry, Fine chemical

Based on the type of technology, the global PAT market has been classified into five major segmentsspectroscopy, chromatography, particle size analysis, capillary electrophoresis, and other technologies.

Key Points: 
  • Based on the type of technology, the global PAT market has been classified into five major segmentsspectroscopy, chromatography, particle size analysis, capillary electrophoresis, and other technologies.
  • Products segment accounted for the largest share of the process analytical technology market, by product & service market in 2021
    The product segment dominates the process analytical technology market, and the trend is expected to continue over the forecast period.
  • In 2021, this segment held the largest share owing to the technological advancements in process analytical techniques that offer operational efficiency and reduce the process cycle time.
  • On-line analysis segment dominated the market in terms of measurement, in 2021
    Process analytical technology tools are used for the timely measurement of Critical Process Parameters (CPP) during the development and manufacturing of a drug.

Process Analytical Technology Market worth $6.1 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, October 21, 2022
Adoption, Critical process parameters, PAT, Product-service system, Growth, ABB, CAGR, Drug development, Research, Waters Corporation, PerkinElmer, Shimadzu, Danaher Corporation, Technology, CPP, Mass spectrometry, Carl Zeiss AG, Agilent Technologies, Safety, Bruker, Chromatography, Biophysics, USD, Biochemistry, Fine chemical

Based on the type of technology, the global PAT market has been classified into five major segmentsspectroscopy, chromatography, particle size analysis, capillary electrophoresis, and other technologies.

Key Points: 
  • Based on the type of technology, the global PAT market has been classified into five major segmentsspectroscopy, chromatography, particle size analysis, capillary electrophoresis, and other technologies.
  • Products segment accounted for the largest share of the process analytical technology market, by product & service market in 2021
    The product segment dominates the process analytical technology market, and the trend is expected to continue over the forecast period.
  • In 2021, this segment held the largest share owing to the technological advancements in process analytical techniques that offer operational efficiency and reduce the process cycle time.
  • On-line analysis segment dominated the market in terms of measurement, in 2021
    Process analytical technology tools are used for the timely measurement of Critical Process Parameters (CPP) during the development and manufacturing of a drug.

Insights on the Spectrometry Global Market to 2031 - Increasing Utilization of Spectrometry Techniques in Pharmaceutical & Biotechnological Companies for Drug Testing is Driving Growth

Retrieved on: 
Monday, October 10, 2022
Kore, Spectrometry, Thermo Fisher Scientific, SCIEX, Growth, Aladdin (food & beverage containers), CAGR, Society, R&D intensity, Porter's five forces analysis, Carbon, Research, Waters Corporation, ASMS, Shimadzu, American Society for Mass Spectrometry, Drinking water, PerkinElmer, Partnership, Danaher Corporation, Electromagnetic radiation, R, Peptide, LECO Corporation, Ionization, Drug discovery, Mass spectrometry, MAM, Agilent Technologies, QC, Raman, Plasma, Benchmarking, Wastewater, College of Arts and Sciences, Bruker, Food, Uranium, Medical imaging, Fine chemical, Retail

Spectrometry is classified into molecular spectrometry, mass spectrometry, and atomic spectrometry.

Key Points: 
  • Spectrometry is classified into molecular spectrometry, mass spectrometry, and atomic spectrometry.
  • The major factor that drives the growth of the spectrometry market is increase in the utilization of spectrometry techniques in pharmaceutical & biotechnological companies for drug testing, drug discovery, protein testing, raw materials testing and for the quality assurance & quality control of the products.
  • On the basis of type, the market is categorized into molecular spectrometry, mass spectrometry, and atomic spectrometry.
  • The report includes the analysis of the regional as well as global world spectrometry market trends, key players, market segments, application areas, and market growth strategies.